Literature DB >> 19553776

Increased frequency of HIV-1 viral load blip rate observed after switching from Roche Cobas Amplicor to Cobas Taqman assay.

Erasmus Smit, Sanjay Bhattacharya, Husam Osman, Steve Taylor.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19553776     DOI： 10.1097/QAI.0b013e3181aa13b3

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  19 in total

1.  Comparison of HIV-1 viral load assay performance in immunological stable patients with low or undetectable viremia.

Authors:  Gudrun Naeth; Robert Ehret; Frank Wiesmann; Patrick Braun; Heribert Knechten; Annemarie Berger
Journal:  Med Microbiol Immunol       Date:  2012-06-15       Impact factor: 3.402

2.  Magnitude of virologic blips is associated with a higher risk for virologic rebound in HIV-infected individuals: a recurrent events analysis.

Authors:  J Troy Grennan; Mona R Loutfy; DeSheng Su; P Richard Harrigan; Curtis Cooper; Marina Klein; Nima Machouf; Julio S G Montaner; Sean Rourke; Christos Tsoukas; Bob Hogg; Janet Raboud
Journal:  J Infect Dis       Date:  2012-04-15       Impact factor: 5.226

3.  Cost ramifications of increased reporting of detectable plasma HIV-1 RNA levels by the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 version 1.0 viral load test.

Authors:  James H Willig; Christa R Nevin; James L Raper; Michael S Saag; Michael J Mugavero; Amanda L Willig; Jeffrey H Burkhardt; Joseph E Schumacher; Victoria A Johnson
Journal:  J Acquir Immune Defic Syndr       Date:  2010-08       Impact factor: 3.731

4.  Darunavir outcomes study: comparative effectiveness of virologic suppression, regimen durability, and discontinuation reasons for three-class experienced patients at 48 weeks.

Authors:  James H Willig; Inmaculada Aban; Christa R Nevin; Jiatao Ye; James L Raper; James A McKinnel; Lori L Delaitsch; Joseph M Mrus; Guy R De La Rosa; Michael J Mugavero; Michael S Saag
Journal:  AIDS Res Hum Retroviruses       Date:  2010-10-21       Impact factor: 2.205

5.  Cross-platform analysis of HIV-1 RNA data generated by a multicenter assay validation study with wide geographic representation.

Authors:  Cheryl Jennings; Brian Harty; Suzanne Granger; Carrie Wager; John A Crump; Susan A Fiscus; James W Bremer
Journal:  J Clin Microbiol       Date:  2012-06-12       Impact factor: 5.948

6.  Performance evaluation of the new Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 for quantification of human immunodeficiency virus type 1 RNA.

Authors:  Suzan Pas; John W A Rossen; Daniel Schoener; Diana Thamke; Annika Pettersson; Reiner Babiel; Martin Schutten
Journal:  J Clin Microbiol       Date:  2010-02-17       Impact factor: 5.948

7.  Regional differences in rates of HIV-1 viral load monitoring in Canada: Insights and implications for antiretroviral care in high income countries.

Authors:  Janet M Raboud; Mona R Loutfy; DeSheng Su; Ahmed M Bayoumi; Marina B Klein; Curtis Cooper; Nima Machouf; Sean Rourke; Sharon Walmsley; Anita Rachlis; P Richard Harrigan; Marek Smieja; Christos Tsoukas; Julio S G Montaner; Robert S Hogg
Journal:  BMC Infect Dis       Date:  2010-02-25       Impact factor: 3.090

8.  Evaluation of quantification of HIV-1 RNA viral load in plasma and dried blood spots by use of the semiautomated Cobas Amplicor assay and the fully automated Cobas Ampliprep/TaqMan assay, version 2.0, in Kisumu, Kenya.

Authors:  Kenneth N Ouma; Sridhar V Basavaraju; Jully A Okonji; John Williamson; Timothy K Thomas; Lisa A Mills; John N Nkengasong; Clement Zeh
Journal:  J Clin Microbiol       Date:  2013-02-06       Impact factor: 5.948

9.  Influence of episodes of intermittent viremia ("blips") on immune responses and viral load rebound in successfully treated HIV-infected patients.

Authors:  Pedro Castro; Montserrat Plana; Raquel González; Anna López; Anna Vilella; Jose M Nicolas; Teresa Gallart; Tomàs Pumarola; José M Bayas; José M Gatell; Felipe García
Journal:  AIDS Res Hum Retroviruses       Date:  2012-12-16       Impact factor: 2.205

10.  Short communication: HIV blips while on antiretroviral therapy can indicate consistently detectable viral levels due to assay underreporting.

Authors:  John M Murray; John J Zaunders; Kersten K Koelsch; Ven Natarajan; Yunden Badralmaa; Kristin McBride; Alexander Carrera; David A Cooper; Sean Emery; Anthony D Kelleher
Journal:  AIDS Res Hum Retroviruses       Date:  2013-08-09       Impact factor: 2.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.